introduct
viral
acut
respiratori
infect
ari
caus
substanti
child
morbid
sensit
molecularbas
assay
aid
viru
detect
clinic
signific
posit
test
remain
uncertain
virus
may
found
acut
ill
healthi
children
describ
diseasepathogen
associ
respiratori
virus
quantifi
virusspecif
attribut
risk
ari
healthi
children
first
year
life
method
one
hundr
fiftyeight
term
newborn
babi
brisban
australia
recruit
progress
longitudin
communitybas
birth
cohort
studi
conduct
septemb
octob
daili
tickbox
diari
captur
predefin
respiratori
symptom
birth
second
birthday
weekli
parentcollect
nasal
swab
batchtest
respiratori
virus
pcr
assay
allow
calcul
virusspecif
attribut
fraction
expos
afe
determin
proport
virusposit
children
whose
ari
symptom
could
attribut
particular
viru
result
nasal
swab
analys
virusposit
viru
codetect
human
rhinovirus
account
posit
swab
virus
detect
ari
episod
swab
asymptomat
period
respiratori
syncyti
viru
afe
ci
human
metapneumoviru
afe
ci
strongli
associ
higher
risk
lower
respiratori
symptom
discuss
strong
associ
respiratori
syncyti
viru
human
metapneumoviru
ari
lower
respiratori
symptom
young
children
manag
within
commun
indic
success
develop
vaccin
two
virus
provid
substanti
health
benefit
viral
acut
respiratori
infect
ari
common
caus
morbid
children
either
synergi
bacteri
pathogen
virusposit
ari
earli
life
associ
develop
wheez
asthma
childhood
adolesc
communitybas
studi
examin
aetiolog
ari
tradit
laboratori
detect
method
remain
templat
understand
childhood
respiratori
viru
epidemiolog
advanc
molecular
diagnost
includ
pcr
test
improv
viru
detect
ari
howev
increas
test
sensit
also
result
virus
detect
asymptomat
individu
clinic
signific
find
respiratori
virus
alway
straightforward
better
understand
proport
infect
symptomat
individu
virus
need
attribut
fraction
expos
afe
provid
inform
percentag
case
among
expos
individu
attribut
exposur
studi
afe
measur
percentag
ari
virusposit
children
attribut
particular
viru
afe
inform
aetiolog
individu
level
key
populationlevel
metric
interpret
posit
specimen
result
assist
estim
true
burden
diseas
thu
guid
prevent
strategi
respiratori
infect
immunis
virusspecif
afe
estim
ari
children
report
infrequ
studi
report
afe
import
methodolog
limit
except
one
commun
key
question
attribut
risk
symptom
acut
respiratori
infect
ari
specif
respiratori
virus
detect
pcr
assay
nasal
swab
sampl
collect
weekli
otherwis
healthi
young
children
attribut
ari
specif
virus
strongest
respiratori
syncyti
viru
human
metapneumoviru
young
children
lower
respiratori
tract
infect
among
dna
virus
test
adenovirus
significantli
associ
increas
risk
symptom
virusspecif
attribut
risk
ari
populationlevel
metric
inform
causal
infer
aetiolog
ari
provid
quantit
estim
rel
proport
virusassoci
ari
commun
yield
import
insight
prioritis
public
health
intervent
studi
investig
recruit
either
highli
select
hospitalis
children
outpati
studi
case
use
control
outpati
clinic
metaanalysi
studi
calcul
virusspecif
afe
includ
studi
employ
hospitalbas
case
ascertain
three
use
communitybas
control
studi
compar
symptomat
asymptomat
group
calcul
odd
ratio
or
rel
risk
without
calcul
afe
moreov
sever
studi
focus
sole
either
specif
virus
outcom
longitudin
communitybas
studi
employ
sensit
molecularbas
assay
regular
frequent
sampl
irrespect
ill
best
suit
explor
relationship
respiratori
viru
detect
ari
symptom
especi
repres
ari
episod
aim
studi
examin
diseasepathogen
associ
respiratori
virus
infant
particip
communitybas
birth
cohort
project
calcul
virusspecif
afe
valu
observ
research
childhood
infecti
diseas
orchid
project
clinicaltri
gov
observ
longitudin
communitybas
birth
cohort
studi
ari
episod
children
second
birthday
particip
abl
leav
studi
temporarili
famili
holiday
rejoin
later
date
conduct
subtrop
citi
brisban
australia
latitud
south
averag
monthli
maximum
temperatur
rang
maximum
rainfal
decemberfebruari
popul
million
septemb
octob
parent
consent
antenat
child
particip
enrol
infant
need
healthi
without
congenit
abnorm
underli
chronic
disord
born
term
week
recruit
progress
year
one
two
metropolitan
hospit
one
privat
one
governmentfund
detail
method
recruit
studi
design
sampl
data
collect
describ
elsewher
children
health
queensland
royal
brisban
women
hospit
univers
queensland
human
research
ethic
committe
approv
studi
follow
recruit
parent
provid
sociodemograph
health
histori
pregnanc
birth
detail
telephon
interview
conduct
everi
month
updat
immunis
feed
childcar
attend
detail
childcar
categoris
formal
regul
care
outsid
child
home
inform
nonregul
care
provid
famili
friend
durat
exclus
breast
feed
birth
introduct
either
milk
formula
solid
parent
train
recognis
respiratori
symptom
provid
diari
card
design
tickbox
format
list
predefin
respiratori
symptom
diagnos
complet
daili
return
regular
mail
monthli
diari
card
modifi
prior
studi
use
success
elsewher
virus
identifi
parentcollect
anterior
nose
swab
infant
birth
weekli
thereaft
specimen
mail
laboratori
take
median
iqr
day
process
store
analysi
swab
batchtest
respiratori
virus
human
rhinoviru
hrv
influenza
b
ifva
ifvb
respiratori
syncyti
viru
b
rsva
rsvb
parainfluenza
virus
human
coronavirus
hcov
human
metapneumoviru
hmpv
adenoviru
adv
human
polyomavirus
wu
wupyv
ki
kipyv
human
use
previous
valid
realtim
pcr
assay
detail
sampl
collect
process
pcr
assay
paramet
qualiti
control
measur
hrv
type
speci
b
c
outlin
onlin
supplementari
text
etabl
specimen
qualiti
assess
test
marker
human
genom
dna
endogen
swab
cyclethreshold
ct
valu
includ
undetect
ct
valu
deem
lesser
qualiti
exclud
part
analysi
new
viru
detect
episod
new
viru
differ
viru
new
speciessubtyp
genu
speci
respect
detect
swab
pcr
test
viru
detect
least
two
neg
interven
swab
viru
detect
least
day
last
posit
swab
symptom
report
day
day
detect
new
viru
ari
defin
new
episod
respiratori
symptom
upper
andor
lower
respiratori
tract
demarc
window
symptomfre
day
upper
respiratori
tract
infect
parentreport
runni
nosenas
congest
dri
cough
doctordiagnos
otiti
media
parentreport
rattli
breath
moist
cough
short
breath
wheez
doctordiagnos
pneumonia
ari
subcategoris
hierarch
either
lower
respiratori
tract
infect
lrti
upper
respiratori
tract
infect
urti
respect
incid
rate
singl
new
viru
detect
episod
vde
per
childyear
calcul
use
poisson
regress
account
analyt
differ
length
time
children
remain
studi
natur
logarithm
number
swab
return
includ
model
offset
swab
remov
incid
rate
calcul
individu
virus
particip
risk
new
vde
posit
consecut
swab
follow
initi
posit
swab
two
swab
last
posit
swab
per
definit
new
vde
swab
lesser
qualiti
avoid
underestim
incid
rate
calcul
incid
rate
viru
assum
children
risk
posit
new
virus
everi
swab
virusspecif
risk
afe
singl
vde
case
ari
lrti
estim
use
generalis
linear
model
binomi
famili
log
link
robust
varianc
estim
calcul
use
sandwich
estim
account
repeat
measur
within
children
analys
lrti
separ
children
infect
like
visit
famili
physician
present
hospit
receiv
antibiot
afe
associ
potenti
risk
factor
age
sex
type
deliveri
gestat
age
birth
season
famili
histori
asthma
eczema
tobacco
smoke
exposur
household
size
matern
educ
statu
mode
feed
categori
childcar
attend
symptomat
asymptomat
viru
detect
examin
use
mixedeffect
logist
regress
child
enter
random
effect
account
repeat
measur
within
children
univari
multivari
analys
conduct
breast
feed
childcar
attend
analys
timevari
variabl
multivari
model
includ
risk
factor
forward
backward
select
virusneg
tabl
respiratori
virus
detect
highqual
nasal
swab
collect
infant
observ
research
childhood
infecti
diseas
orchid
birth
cohort
first
year
life
incid
childyear
present
overal
first
second
year
life
separ
potenti
particip
approach
elig
singleton
infant
famili
enrol
two
famili
enrol
two
sibl
figur
seven
exclud
subsequ
one
inelig
born
week
six
fail
provid
swab
calcul
incid
rate
total
swab
submit
children
lesserqu
swab
virusposit
virusneg
remov
analys
swab
submit
child
second
birthday
leav
swab
infant
figur
overal
consid
virusposit
ari
asymptomat
episod
retain
virusposit
swab
ct
valu
remov
swab
miss
symptom
data
give
final
dataset
swab
particip
particip
submit
swab
high
ct
valu
swab
correspond
symptom
data
withdraw
earli
studi
tabl
swab
taken
symptomat
period
asymptomat
period
swab
taken
time
symptomat
period
posit
viru
new
vde
overal
swab
taken
asymptomat
period
posit
viru
new
vde
new
singl
viru
detect
tabl
tabl
show
new
vde
involv
singl
virus
hrva
hrvc
ifva
rsva
rsvb
hmpv
adv
statist
signific
posit
afe
valu
indic
significantli
often
associ
ari
episod
asymptomat
period
tabl
lower
respiratori
tract
infect
asymptomat
singl
new
viru
detect
risk
ratio
attribut
fraction
respiratori
viru
children
orchid
birth
cohort
swab
continu
contrast
wupyv
kipyv
frequent
detect
asymptomat
period
low
point
estim
afe
indic
less
like
caus
ari
total
ari
swab
submit
ari
episod
includ
swab
taken
day
day
last
day
ill
remain
ari
ari
urti
lrti
swab
viru
detect
period
rsv
hmpv
strongli
associ
lrti
asymptomat
detect
tabl
higher
risk
ratio
virus
signific
associ
lrti
hrvc
detect
weaker
interestingli
codetect
specimen
among
strongest
afe
valu
ari
lrti
tabl
hrv
frequent
detect
viru
group
usual
combin
dna
virus
see
onlin
supplementari
etabl
investig
sensit
result
includ
lesser
qualiti
swab
reanalys
data
exclud
virusposit
swab
lesser
qualiti
found
minim
chang
afe
calcul
tabl
see
onlin
supplementari
etabl
independ
risk
factor
associ
symptomat
rather
asymptomat
vde
includ
increas
age
particularli
month
viru
infect
nonsumm
season
tabl
regress
model
reveal
childcar
attend
also
independ
associ
higher
rate
vde
symptomat
asymptomat
risk
factor
found
associ
asymptomat
vde
healthi
children
orchid
communitybas
birth
cohort
experienc
incid
rate
new
vde
per
childyear
first
year
life
hrv
play
domin
role
overal
respiratori
virus
detect
pcr
regular
weekli
swab
least
ari
asymptomat
period
weekli
nasal
swab
posit
pcr
respiratori
virus
account
new
vde
demonstr
evid
attribut
ari
rna
virus
includ
hrv
hrva
hrvc
influenza
ifva
parainfluenza
rsv
rsva
rsvb
hcov
hmpv
adv
singl
dna
viru
repres
virus
detect
significantli
often
children
ari
asymptomat
period
statist
signific
posit
afe
largest
associ
observ
rsv
hmpv
strongli
associ
lrti
respiratori
virus
increas
age
month
nonsumm
month
childcar
attend
independ
risk
factor
symptomat
vde
age
host
risk
factor
symptomat
infect
also
note
studi
presum
due
protect
afford
matern
transplacent
breastmilk
antibodi
young
environment
risk
factor
season
childcar
attend
ari
may
relat
intens
opportun
exposur
set
experienc
young
children
virusspecif
attribut
ari
quantifi
identifi
vde
asymptomat
period
calcul
virusspecif
afe
infrequ
report
metric
help
determin
rel
causal
role
differ
virus
popul
level
limit
afe
approach
inform
aetiolog
individu
level
individu
case
differenti
true
posit
test
identifi
viru
respons
ari
fals
posit
result
asymptomat
viru
shed
nevertheless
know
afe
respiratori
virus
help
inform
clinician
like
clinic
signific
detect
one
virus
nasal
swab
specimen
taken
infant
young
children
ari
episod
assign
group
aetiolog
fraction
virus
detect
child
importantli
afe
estim
appli
studi
ari
differ
set
estim
true
burden
diseas
commun
thu
inform
virus
prioritis
futur
public
health
polici
intervent
previou
studi
overestim
afe
valu
use
or
rather
rr
calcul
or
overestim
effect
size
event
rare
occur
ari
children
studi
princip
crosssect
hospitalbas
often
poorli
match
control
consequ
estim
afe
lower
report
elsewher
surpris
believ
like
provid
accur
estim
ari
lrti
burden
attribut
virus
broader
paediatr
popul
proport
asymptomat
infect
studi
highlight
risk
extrapol
hospitalbas
data
sick
children
commun
set
previous
signific
detect
virus
pcr
temper
concern
may
incub
unrel
subclin
infect
repres
continu
viru
nucleic
acid
shed
recent
ari
resolv
intens
longitudin
specimen
symptom
sampl
cohort
well
definit
vde
symptomat
vde
use
help
identifi
nascent
subclin
infect
context
observ
emphasis
frequenc
subclin
infect
respiratori
virus
young
children
otherwis
well
may
act
import
silent
reservoir
infect
similar
observ
conclus
report
recent
household
studi
involv
child
adult
contact
symptomat
case
laboratoryconfirm
influenza
nevertheless
addit
influenza
establish
virus
hrv
rsv
hmpv
also
import
commun
respiratori
pathogen
especi
latter
two
virus
potenti
candid
vaccin
therapeut
intervent
contrast
novel
dna
virus
hpyv
low
afe
calcul
ari
lrti
despit
higher
detect
rate
howev
suggest
cohort
synergi
may
exist
multipl
virus
caus
ari
unexpectedli
involv
mostli
hrv
dna
virus
find
warrant
studi
expect
childday
expect
swab
return
good
retent
rate
given
intens
prolong
natur
studi
particip
famili
analysi
incid
rate
ari
particip
withdrew
studi
differ
period
show
clear
associ
time
dropout
ari
incid
regular
parentcollect
nasal
swab
avoid
need
home
visit
research
staff
clinic
attend
ari
minimis
possibl
bias
estim
ari
event
specimen
avail
lose
famili
fail
seek
healthcar
moreov
regular
weekli
nasal
swab
collect
increas
likelihood
viru
detect
ari
episod
rather
reli
simpli
result
singl
specimen
previou
work
found
sensit
pcr
techniqu
parentcollect
nose
nosethroat
swab
sent
laboratori
standard
mail
compar
sensit
nasopharyng
swab
obtain
healthcar
worker
longitudin
data
collect
also
allow
assess
asymptomat
statu
consid
past
futur
ill
histori
virus
detect
day
ari
symptom
develop
therefor
less
like
yield
falseposit
find
also
import
limit
consid
reduc
chanc
falseneg
test
result
exclud
analysi
swab
intern
control
human
dna
either
undetect
present
low
level
exclud
virusposit
virusneg
swab
avoid
overestim
incid
preval
rate
addit
virus
detect
rare
particular
influenza
find
reflect
commun
studi
nevertheless
limit
abil
provid
precis
afe
estim
agent
also
exclud
codetect
individu
viru
assess
multipl
aetiolog
agent
make
individu
contribut
agent
difficult
ascertain
analys
separ
look
associ
pattern
individu
virus
symptom
inform
doctordiagnos
otiti
media
pneumonia
captur
daili
diari
valid
maximis
accuraci
parent
train
recognis
symptom
commenc
studi
healthcar
workervalid
symptom
would
ideal
studi
scale
logist
challeng
without
parent
particip
studi
design
use
previous
other
shown
parent
train
recognis
symptom
interest
often
reliabl
healthcar
profession
rate
ari
includ
associ
wheez
compar
commun
studi
final
common
type
studi
famili
cohort
advantag
background
ari
episod
predominantli
mildtomoder
natur
mani
children
studi
firstborn
advantag
famili
factor
thought
decreas
rate
ari
secular
chang
australia
led
increas
proport
children
famili
attend
childcar
earlier
age
sector
popul
slightli
higher
proport
cohort
attend
form
care
age
month
compar
children
australian
popul
childcar
attend
independ
risk
factor
ari
moreov
incid
ari
orchid
cohort
compar
report
age
group
rsv
hrvassoci
ari
approxim
communitybas
studi
conduct
temper
climat
australia
perth
europ
find
cohort
remain
valid
provid
import
estim
commun
respiratori
viru
exposur
ari
australian
children
subtrop
urban
set
respiratori
virus
particularli
hrv
detect
remark
frequenc
healthi
australian
children
first
year
life
least
onethird
new
vde
unaccompani
symptom
molecular
method
use
increasingli
detect
respiratori
virus
young
children
studi
provid
insight
support
attribut
virusspecif
ari
age
group
manag
within
commun
establish
rna
respiratori
virus
adv
strongli
associ
symptomat
asymptomat
infect
associ
found
newli
describ
dna
virus
hpyv
data
emphasis
high
commun
level
hrv
circul
among
children
importantli
also
provid
evid
suggest
current
clinic
trial
candid
rsv
hmpv
vaccin
seek
protect
infant
sever
diseas
hospitalis
might
also
deliv
substanti
health
benefit
young
children
within
commun
correct
notic
articl
correct
sinc
publish
onlin
first
figur
updat
includ
miss
figur
legend
